[ad_1] An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York…
Category: Health
Masimo activist Politan presents ‘last chance’ for shareholders to force change at med-tech company
[ad_1] Founder and CEO of Masimo Joe Kiani addresses a press conference in Bangalore on Jan.…
Plant-based meat substitutes may be healthier for the heart than real meat
[ad_1] Plant-based meat alternatives, despite being ultraprocessed, may be healthier for the heart than meat, a…
CDC issues dengue fever alert in the U.S.
[ad_1] Close-up of a yellow-fever mosquito biting human skin, it’s a culicidae vector of malaria, yellow…
Starbucks debuts fruity energy drink less than two months after Panera discontinues highly caffeinated Charged Lemonade
[ad_1] Starbucks on Tuesday launched a drink at stores nationwide called Iced Energy, which has up…
Novo Nordisk to build $4.1 billion North Carolina facility to boost output of Wegovy, Ozempic
[ad_1] Novo Nordisk’s new manufacturing facility in Clayton, North Carolina. Courtesy: Novo Nordisk Novo Nordisk on…
Eli Lilly expects FDA decision on weight loss drug Zepbound for sleep apnea as early as end of the year
[ad_1] Eli Lilly on Friday said it applied for U.S. approval of its weight loss drug Zepbound for…
Neuralink competitor Paradromics gears up to test its brain implant on humans
[ad_1] Neurotech startup Paradromics will be putting its brain implant on trial next year, as the…
FDA approves Merck vaccine designed to protect adults from bacteria that can cause pneumonia, serious infections
[ad_1] Zoom In IconArrows pointing outwards Merck’s new pneumococcal vaccine. Courtesy: Merck The Food and Drug…
How Eli Lilly is managing soaring demand for GLP-1s, according to outgoing CFO Anat Ashkenazi
[ad_1] A pharmacist holds boxs of Eli Lilly & Co. Mounjaro brand tirzepatide medication arranged at…
The 4 key things we’re watching in the stock market this holiday-shortened week
[ad_1] The Nasdaq Composite inched higher Friday to claim its fifth straight record close, as new…
Google-backed Tempus AI closes first day of trading up 9% in Nasdaq stock market debut
[ad_1] Tempus AI, a health-care diagnostics company that uses AI to interpret medical tests to help…